NCRC Testifies on MBDA before House Appropriations CommitteeBy NCRC / March 22, 2012 / Testimony & Regulatory Comments / 1 minute of reading Download the PDF of the full testimony  buy fildena online fildena online generic FacebookShare on XLinkedInWhatsAppEmailCopy Link
NCRC Opposes 2030 Census Changes That Threaten Data Accuracy and Civil Rights Testimony & Regulatory Comments
NCRC submits opposition to Block’s national trust bank charter application Testimony & Regulatory Comments
NCRC Opposes HUD’s Proposed Removal of Disparate Impact Provisions from Title VI Regulations Testimony & Regulatory Comments
